EpisodicStatinMig. A multicentre, triple blind, placebo controlled, parallel group study of atorvastatin in episodic migraine. EudraCT Number 2022-502176-23-01. Role: Local PI. Sponsor institution: St. Olav’s Hospital, Trondheim, Norway
Chronic StatinMig. A multicentre, triple blind, placebo controlled, parallel group study of atorvastatin in chronic migraine. EudraCT Number 2022-502177-42-02. Role: Local PI. Sponsor institution: St. Olav’s Hospital, Trondheim, Norway
Nurse intervention Trial. Follow-up from headache nurse: An open randomized. REK #2023/554940. Role: Local PI. Sponsor institution: St. Olav’s Hospital, Trondheim, Norway
Interventional, randomized, double-blind, parallel-group, placebo-controlled study of add-on eptinezumab treatment to brief educational intervention for the preventive treatment of migraine in patients with dual diagnosis of migraine and medication overuse headache (RESOLUTION). EudraCT Number 2021-003049-40. Role: Local PI. Sponsor institution: H. Lundbeck A/S
MiBlock Study - Botulinum toxin type A blockade of the sphenopalatine ganglion in treatment-refractory chronic migraine: A randomized, placebo-controlled, triple-blind (blinded statistician), multicentre, parallel group proof-of-concept, phase 3 study. EudraCT Number 2018-004053-24. Role: Sub-PI. Sponsor institution: St. Olav’s Hospital and NTNU, Trondheim
Faisal F, Danelakis A, Bjørk MH, Winsvold B, Matharu M, Nachev P, Hagen K, International Headache Genetics Consortium, Tronvik E, Stubberud A(2025) Prediction of new-onset migraine using clinical-genotypic data from the HUNT Study: a machine learning analysis J Headache Pain, 26(1), 70 DOI 10.1186/s10194-025-02014-2, PubMed 40197205
Hatzikotoulas K, Southam L, Stefansdottir L, Boer CG, McDonald ML, Pett JP, Park YC, Tuerlings M, Mulders R, Barysenka A, Arruda AL, Tragante V, Rocco A, Bittner N, Chen S, Horn S, Srinivasasainagendra V, To K, Katsoula G, Kreitmaier P, Tenghe AMM, Gilly A, Arbeeva L, Chen LG, de Pins AMet al.(2025) Translational genomics of osteoarthritis in 1,962,069 individuals Nature(in press) DOI 10.1038/s41586-025-08771-z, PubMed 40205036
Klieverik VM, Kanning JP, Rissanen IL, Rannikmae K, Martinsen AE, Winsvold BS, Geerlings MI, Ruigrok YM(2025) Development and external validation of the SMA2SH2ERS risk prediction model for aneurysmal subarachnoid haemorrhage in the general population: a population-based prospective cohort study BMJ Open, 15(1), e091756 DOI 10.1136/bmjopen-2024-091756, PubMed 39819926
